{"id":"https://openalex.org/W2409438593","doi":"https://doi.org/10.1021/jm4007033","title":"Current Status of the Research and Development of Diacylglycerol O-Acyltransferase 1 (DGAT1) Inhibitors","display_name":"Current Status of the Research and Development of Diacylglycerol O-Acyltransferase 1 (DGAT1) Inhibitors","alternate_titles":[],"publication_year":2013,"publication_date":"2013-09-03","ids":{"openalex":"https://openalex.org/W2409438593","doi":"https://doi.org/10.1021/jm4007033","mag":"2409438593","pmid":"https://pubmed.ncbi.nlm.nih.gov/23919406"},"language":"en","primary_location":{"id":"doi:10.1021/jm4007033","doi":"https://doi.org/10.1021/jm4007033","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm4007033","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2409438593"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008459770","display_name":"Robert J. DeVita","orcid":"https://orcid.org/0000-0002-2671-8497","observed_orcids":["https://orcid.org/0000-0002-2671-8497","https://orcid.org/0000-0002-5489-0956"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Robert J. DeVita","raw_affiliation_strings":["RJD Medicinal Chemistry and Drug Discovery Consulting, 332 W.\rDudley Avenue, Westfield, New Jersey 07090, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RJD Medicinal Chemistry and Drug Discovery Consulting, 332 W.\rDudley Avenue, Westfield, New Jersey 07090, United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113690873","display_name":"Shirly Pinto","orcid":"https://orcid.org/0009-0002-0935-5580","observed_orcids":["https://orcid.org/0009-0002-0935-5580"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shirly Pinto","raw_affiliation_strings":["Department\rCardiovascular and Diabetes Discovery, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department\rCardiovascular and Diabetes Discovery, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5008459770"],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":8.77,"has_fulltext":false,"cited_by_count":110,"citation_normalized_percentile":{"value":0.98477099,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"56","issue":"24","first_page":"9820","last_page":"9825"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.8314999938011169,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.8314999938011169,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11844","display_name":"Lipid metabolism and biosynthesis","score":0.14149999618530273,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.005400000140070915,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dgat1-inhibitors","display_name":"DGAT1 inhibitors","score":0.8600000143051147},{"id":"https://openalex.org/keywords/diacylglycerol-o-acyltransferase-1","display_name":"diacylglycerol O-acyltransferase 1","score":0.9950000047683716},{"id":"https://openalex.org/keywords/triacylglycerol-biosynthesis","display_name":"triglyceride synthesis","score":0.824999988079071},{"id":"https://openalex.org/keywords/intestinal-lipid-absorption","display_name":"intestinal lipid absorption","score":0.6499999761581421},{"id":"https://openalex.org/keywords/hepatitis-c-virus","display_name":"hepatitis C virus","score":0.6240000128746033},{"id":"https://openalex.org/keywords/familial-chylomicronemia","display_name":"familial chylomicronemia","score":0.8930000066757202},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.8989999890327454},{"id":"https://openalex.org/keywords/target-engagement","display_name":"target engagement","score":0.7879999876022339},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.3930000066757202},{"id":"https://openalex.org/keywords/metabolic-disorders","display_name":"metabolic disorders","score":0.578000009059906}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7280647158622742},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6563128232955933},{"id":"https://openalex.org/C36020004","wikidata":"https://www.wikidata.org/wiki/Q106951674","display_name":"Diacylglycerol kinase","level":4,"score":0.6049918532371521},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5517805814743042},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.524843692779541},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5204532146453857},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29915398359298706},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.25418972969055176},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.21481961011886597},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.12993180751800537},{"id":"https://openalex.org/C195794163","wikidata":"https://www.wikidata.org/wiki/Q420877","display_name":"Protein kinase C","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051048","descriptor_name":"Diacylglycerol O-Acyltransferase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051048","descriptor_name":"Diacylglycerol O-Acyltransferase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm4007033","doi":"https://doi.org/10.1021/jm4007033","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm4007033","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:23919406","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23919406","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1805953928","https://openalex.org/W1965664368","https://openalex.org/W1993583808","https://openalex.org/W2010895424","https://openalex.org/W2033043158","https://openalex.org/W2039481955","https://openalex.org/W2047101066","https://openalex.org/W2048328206","https://openalex.org/W2055418232","https://openalex.org/W2075182577","https://openalex.org/W2078126254","https://openalex.org/W2079599967","https://openalex.org/W2080450487","https://openalex.org/W2094519622","https://openalex.org/W2101217072","https://openalex.org/W2124311778","https://openalex.org/W2401086991"],"related_works":["https://openalex.org/W2010363699","https://openalex.org/W3114668275","https://openalex.org/W2765941116","https://openalex.org/W2090708818","https://openalex.org/W2328293998","https://openalex.org/W2990317354","https://openalex.org/W2782597403","https://openalex.org/W1583529364","https://openalex.org/W2105767856","https://openalex.org/W2801453912"],"abstract_inverted_index":{"Diacylglycerol":[0],"O-acyltransferase":[1],"1":[2],"(DGAT1)":[3],"has":[4],"recently":[5],"become":[6],"a":[7,110,121,139,165],"highly":[8],"interesting":[9],"target":[10,59,103,141],"for":[11,17,33,130],"metabolic":[12],"disorders":[13],"as":[14,16,83,138],"well":[15],"hepatitis":[18],"C":[19],"virus":[20],"(HCV).":[21],"DGAT1":[22,74,137,159],"processes":[23],"diacylglycerol":[24],"to":[25,101,123,144,170],"triglycerides":[26,68],"in":[27,114,120],"the":[28,34,39,55,64,102,106,172],"final":[29],"step":[30],"of":[31,36,48,51,58,66,71,105,109,136,158,168,175],"resynthesis":[32],"absorption":[35],"fat":[37],"across":[38],"intestine.":[40],"Pharmaceutical":[41],"companies":[42],"have":[43,53,91],"developed":[44],"many":[45],"novel":[46],"inhibitors":[47,160],"DGAT1,":[49],"several":[50],"which":[52,150],"reached":[54],"clinic.":[56],"Proof":[57],"engagement":[60],"was":[61],"achieved":[62],"with":[63,73,94,126],"observation":[65],"reduced":[67],"upon":[69,164],"treatment":[70],"humans":[72],"inhibitors;":[75],"however,":[76],"there":[77],"were":[78],"gastrointestinal":[79],"adverse":[80,89,148],"events":[81,90],"such":[82],"nausea,":[84],"diarrhea,":[85],"and":[86,97],"vomiting.":[87],"These":[88],"been":[92],"reported":[93],"multiple":[95],"compounds":[96],"are":[98,118,151],"possibly":[99,152],"linked":[100],"because":[104],"recent":[107],"identification":[108],"human":[111],"cohort":[112],"deficient":[113],"DGAT1.":[115],"Clinical":[116],"studies":[117],"continuing":[119],"trial":[122],"treat":[124],"patients":[125],"an":[127],"orphan":[128],"indication":[129],"familial":[131],"chylomicronemia.":[132],"The":[133,155],"full":[134],"potential":[135],"therapeutic":[140],"will":[142,161],"need":[143],"overcome":[145],"observed":[146],"clinical":[147],"events,":[149],"mechanism":[153],"based.":[154],"widespread":[156],"use":[157],"ultimately":[162],"depend":[163],"better":[166],"understanding":[167],"how":[169],"improve":[171],"GI":[173],"tolerability":[174],"these":[176],"agents.":[177]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2409438593","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":18},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
